Many unconventional therapies (e.g. dietary, phytotherapy, acupuncture
, homeopathy) ae well known and often applied, but their efficacy has
hardly been proven. New trial designs and study components must be fou
nd to meet the specific demands of the particular unconventional thera
py on one hand and keep the high methodological standard of controlled
clinical trials on the other hand. Biometricians and unconventional t
herapists are challenged to develop such designs. Typical problems in
designing studies of unconventional therapies include that placebo is
not possible, therapies cannot be masked, outcome variables are not re
liable, therapy is highly individualized, and studies on the efficacy
of soft therapies require many patients and long treatment periods. St
udies with unconventional therapies should be performed by practitione
rs (because they use these therapies), but this leads to further probl
ems. Some solutions are given in examples: A study is described invest
igating the herbal remedy Kava-Kave for patients in the stat of anxiet
y, tension and restlessness; a study on classical homeopathy for chron
ical headaches is specified; some designs for dietary studies in patie
nts with rheumatoid arthritis are compared. A design called ,,cross-al
location of patients to two treatments with randomized option'' are de
scribed and discussed. the ,, change-to-open-label design'' could be u
seful to investigate soft and natural therapies which require studies
with many patients and long-term treatment.